Phase II study of carboplatin and edatrexate (10-EdAM) with leucovorin rescue for patients with recurrent squamous cell carcinoma of the head and neck
โ Scribed by Martin H. Huber; Isaiah W. Dimery; Steven E. Benner; Scott M. Lippman; Mihran Shirinian; Benjamin Esparaz; Daniel Frenning; Cherie Guillory-Perez; Waun Ki Hong
- Publisher
- Springer US
- Year
- 1994
- Tongue
- English
- Weight
- 389 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0167-6997
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## BACKGROUND. The activity of the combination of carboplatin and liposomal doxorubicin was tested in a Phase II study of patients with recurrent cervical carcinoma. ## METHODS. The combination of carboplatin (area under the concentration curve [AUC], 5) and liposomal doxorubicin (Doxil; starti
## Abstract ## BACKGROUND This Phase II trial was conducted to determine the response rate, particularly of the primary sites, tolerability, and toxicity of induction chemotherapy of paclitaxel, ifosfamide, and carboplatin for patients with previously untreated locally advanced squamous cell carci